Literature DB >> 12890432

Serotonin, serotonin 5-HT(1A) receptors and dopamine in blood peripheral lymphocytes of major depression patients.

O Fajardo1, J Galeno, M Urbina, I Carreira, L Lima.   

Abstract

There are increasing evidences of cell markers present in the immune and the nervous systems. These include neurotransmitter receptors and transporters. Serotonin receptor subtypes are related to depression and also have been shown to be present in certain cells of the immune system. In the present report, we determined the presence of 5-HT(1A) receptors by the binding of the selective agonist 8-hydroxy-2-(di-n-propyl-amino)tetralin in lymphocytes of peripheral blood isolated by Ficoll/Hypaque gradients from controls and depressed patients. The capacity of these receptors was around 24 fmol/10(6) cells in both groups of subjects, without significant difference among them. The affinity was in the nM range and either differ between controls and patients. Serotonin, 5-hydroxyindoleacetic acid, dopamine and 3,4-dihydroxyphenylacetic acid were determined by HPLC with electrochemical detector. There were no significant differences between controls and major depression patients in the values obtained for rich and poor platelet plasma or in the isolated cells. However, there was a reduction in serotonin turnover rate indicated by an increase in the ratio serotonin/5-hydroxyindoleacetic acid, but not in that of dopamine, in lymphocytes of major depression patients. Thus, there is a serotonergic dysfunction in immune circulating cells of major depression patients, without changes in the number of 5-HT(1A) receptors, although the coupling of these receptors to transduction mechanisms could be affected and may be related to the alteration of 5-HT turnover rate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890432     DOI: 10.1016/S1567-5769(03)00116-4

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  8 in total

Review 1.  The serotonin1A receptor: a representative member of the serotonin receptor family.

Authors:  Thomas J Pucadyil; Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

2.  The human serotonin1A receptor exhibits G-protein-dependent cell surface dynamics.

Authors:  Thomas J Pucadyil; Amitabha Chattopadhyay
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

3.  Serum serotonin levels are not useful in diagnosing fibromyalgia.

Authors:  Gabriel Jaschko; Urs Hepp; Magdalena Berkhoff; Margrit Schmet; Beat A Michel; Steffen Gay; Haiko Sprott
Journal:  Ann Rheum Dis       Date:  2007-09       Impact factor: 19.103

4.  Comparison of psychological symptoms and serum levels of neurotransmitters in Shanghai adolescents with and without internet addiction disorder: a case-control study.

Authors:  Hong-Xia Zhang; Wen-Qing Jiang; Zhi-Guang Lin; Ya-Song Du; Alasdair Vance
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

5.  The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders.

Authors:  Francesca R Buttarelli; Alessandra Fanciulli; Clelia Pellicano; Francesco E Pontieri
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

Review 6.  Immune Responses Regulated by Cannabidiol.

Authors:  James M Nichols; Barbara L F Kaplan
Journal:  Cannabis Cannabinoid Res       Date:  2020-02-27

Review 7.  Gene expression studies in Depression development and treatment: an overview of the underlying molecular mechanisms and biological processes to identify biomarkers.

Authors:  Nicole Mariani; Nadia Cattane; Carmine Pariante; Annamaria Cattaneo
Journal:  Transl Psychiatry       Date:  2021-06-08       Impact factor: 6.222

8.  mRNA Levels of MAOA and 5-HT 2 A Receptor in Patients With Pathological Internet Use: Correlations With Comorbid Symptoms.

Authors:  Mimi Qiu; Chenchen Zhang; Yu Dai; Lingrui Zhang; Yang Wang; Wei Peng; Yalin Chen; Chao Wen; Hui Li; Tianmin Zhu
Journal:  Front Psychiatry       Date:  2021-07-16       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.